TITLE

The possible role of the ubiquitin proteasome system in the development of atherosclerosis in diabetes

AUTHOR(S)
Marfella, Raffaele; D'Amico, Michele; Di Filippo, Clara; Siniscalchi, Mario; Carlo sasso, Ferdinando; Ferraraccio, Franca; Rossi, Francesco; Paolisso, Giuseppe
PUB. DATE
January 2007
SOURCE
Cardiovascular Diabetology;2007, Vol. 6, p35
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
We have reviewed the impact of the ubiquitin proteasome system (UPS) on atherosclerosis progression of diabetic patients. A puzzle of many pieces of evidence suggests that UPS, in addition to its role in the removal of damaged proteins, is involved in a number of biological processes including inflammation, proliferation and apoptosis, all of which constitute important characteristics of atherosclerosis. From what can be gathered from the very few studies on the UPS in diabetic cardiovascular diseases published so far, the system seems to be functionally active to a different extent in the initiation, progression, and complication stage of atherosclerosis in the diabetic people. Further evidence for this theory, however, has to be given, for instance by specifically targeted antagonism of the UPS. Nonetheless, this hypothesis may help us understand why diverse therapeutic interventions, which have in common the ability to reduce ubiquitin-proteasome activity, can impede or delay the onset of diabetes and cardiovascular diseases (CVD). People with type 2 diabetes are disproportionately affected by CVD, compared with those without diabetes. The prevalence, incidence, and mortality from all forms of CVD (myocardial infarction, cerebro-vascular disease and congestive heart failure) are strikingly increased in persons with diabetes compared with those withoutdiabetes. Furthermore, diabetic patients have not benefited by the advances in the management of obesity, dyslipidemia, and hypertension that have resulted in a decrease in mortality for coronary heart disease (CHD) patients without diabetes. Nevertheless, these risk factors do not fully explain the excess risk for CHD associated with diabetes. Thus, the determinants of progression of atherosclerosis in persons with diabetes must be elucidated. Beyond the major risk factors, several studies have demonstrated that such factors, strictly related to diabetes, as insulin-resistance, post-prandial hyperglycemia and chronic hyperglycemia play a role in the atherosclerotic process and may require intervention. Moreover, it is important to recognize that these risk factors frequently "cluster" inindividual patients and possibly interact with each other, favouring the atherosclerosis progression toward plaque instability. Thus, a fundamental question is, "which is the common soil hypothesis that may unifying the burden of all these factors on atherosclerosis of diabetic patients? Because evidences suggest that insulin-resistance, diabetes and CHD share in common a deregulation of ubiquitin-proteasome system (UPS), the major pathway for nonlysosomal intracellular protein degradation in eucaryotic cells, in this review ubiquitin-proteasome deregulation is proposed as the common persistent pathogenic factor mediating the initial stage of the atherosclerosis as well as the progression to complicated plaque in diabetic patients.
ACCESSION #
35113302

 

Related Articles

  • Seven-year mortality in heart failure patients with undiagnosed diabetes: an observational study.  // Cardiovascular Diabetology;2011, Vol. 10 Issue 1, p39 

    The article offers information on the research conducted by the authors related to seven-year mortality in heart failure patients with undiagnosed diabetes. It states that the study observed the patients with type 2 diabetes mellitus and heart failure have adverse clinical outcomes, but the...

  • Novel Risk Factors and the Prediction of Type 2 Diabetes in the Atherosclerosis Risk in Communities (ARIC) Study. RAYNOR, L. A.; PANKOW, JAMES S.; DUNCAN, BRUCE B.; SCHMIDT, MARIA I.; HOOGEVEEN, RON C.; PEREIRA, MARK A.; YOUNG, J. HUNTER; BALLANTYNE, CHRISTIE M. // Diabetes Care;Jan2013, Vol. 36 Issue 1, p70 

    OBJECTIVE--The objective of this study was to determine potential added value of novel risk factors in predicting the development of type 2 diabetes beyond that provided by standard clinical risk factors. RESEARCH DESIGN AND METHODS--The Atherosclerosis Risk in Communities (ARIC) Study is a...

  • TYPE 2 DIABETES MELLITUS AS A CONDITION BETWEEN DYSLIPIDEMIA AND INFLAMATORY SYNDR. Bădulescu, Oana; Bădescu, Codruţa; Ciocoiu, Manuela; Bădescu, Magda // Annals of the Romanian Society for Cell Biology;2012, Vol. 17 Issue 1, p169 

    Diabetes mellitus (DM) is a medical condition associated with evolving atherosclerosis and with a high prevalence of macrovascular diseases which is the main cause of morbidity and mortality in diabetic patients. The major objectives of our study were: the investigation of the inflammatory...

  • Are Thiazolidinediones (TZDs) Safe?  // Clinical Cardiology Alert;Nov2007, Vol. 26 Issue 11, p1 

    The article focuses on the safety of thiazolidinediones (TZDs), rosiglitazone and pioglitazone. A paper published in the "Journal of American Medical Association" associated pioglitazone with lower risk of death, myocardial infarction or stroke among patients with diabetes. Another paper linked...

  • Family histories of Type II diabetes and hypertension predict intima—media thickness in patients with Type I diabetes S. Mäkimattila et al.: Predictors of intima—media thickness in Type I diabetes. Mäkimattila, S.; Ylitalo, K.; Schlenzka, A.; Taskinen, M.-R.; Summanen, P.; Syvänne, M.; Yki-Järvinen, H. // Diabetologia;May2002, Vol. 45 Issue 5, p711 

    Aims/hypothesis. Hyperglycaemia predicts microvascular complications but data on macrovascular disease are limited. We searched for predictors of carotid artery intima–media thickness in young adults with Type I (insulin-dependent) diabetes mellitus. Methods. A total of 71 children (F/M =...

  • Correlation between reactive oxygen metabolites & atherosclerotic risk factors in patients with type 2 diabetes mellitus. Kazuhiko Kotani; Kokoro Tsuzaki; Nobuyuki Taniguchi; Naoki Sakane // Indian Journal of Medical Research;Apr2013, Vol. 137 Issue 4, p742 

    Background & objectives: Oxidative stress plays important roles in the pathophysiology of type 2 diabetes mellitus (T2DM). The diacron reactive oxygen metabolites (d-ROMs) test has been used in the clinics. The present study was aimed to investigate the correlation of the oxidative stress...

  • Insulin Resistance and Carotid Atherosclerosis in Subjects with Type 2 Diabetes. Park, Seok Won; Ahn, Chul Woo; Kim, Dae Jung; Duk Song, Young; Choi, Young Ju; Huh, Byung Wook; Park, Jung Mee; Lee, Eun-Jig; Jee, Sun-Ha; Huh, Kap Bum // Diabetes;Jun2007 Supplement 1, Vol. 56, pA70 

    Insulin resistance (IR) may provide the crucial link between type 2 diabetes and cardiovascular disease (CVD). The associations between IR and CVD or its surrogate such as intima-media thickness (IMT) have been documented mainly in subjects with varying glucose tolerance. But, it is not well...

  • The spark of life. MORELLO, GAETANO // Chiropractic Economics;10/29/2013, Vol. 59 Issue 17, p25 

    No abstract available.

  • The True Overall Mortality of Unselected Nephropathic Type 2 Diabetic Patients With Mild to Moderate Renal Insufficiency. Biesenbach, Georg; Janko, Otmar // Diabetes Care;May2003, Vol. 26 Issue 5, p1639 

    Investigates the overall mortality of unselected nephropathic Type 2 diabetic patients with mild to moderate renal insufficiency. Occurrence of cardiovascular disease and heart failure; Measurement of creatinine in serum and urine, creatinine clearance and blood pressure; Five-year mortality...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics